Mohammed Hassan arrived in Canada from a Kenyan refugee camp in September 2015, 46 years old and crippled by such pain that he walked like a man decades older. His pain had grown slowly. It began as stiffness in his…
Read More
Researchers unlock TB vaccine puzzle in findings that could save millions of newborns
An international research team has identified the mechanism behind one of science’s most enduring mysteries: what makes the 100-year-old tuberculosis (TB) vaccine so effective at preventing newborn deaths from diseases other than TB? The ability of Bacillus Calmette-Guérin (BCG)—one of…
Read More
Short-Course Rifamycin-Based Regimens Preferred for Latent TB
FRIDAY, Feb. 14, 2020 — For treatment of latent tuberculosis infection (LTBI), short-course rifamycin-based regimens are preferred over longer-course isoniazid monotherapy, according to guidelines published in the Feb. 14 issue of the U.S. Centers for Disease Control and Prevention Morbidity…
Read More